Table 2: Outcomes of esomeprazole- and pantoprazole-based triple therapy.

EAC group
(n = 208)
PAC group
(n = 245)
P value

Eradication rate
 Intention-to-treat72% (150/208)55% (135/245)<.05
 Per-protocol91% (150/165)72% (135/187)<.05
Adverse events19% (39/208)17% (42/245).712
Compliance87% (181/208)91% (223/245).083